NCT06819761View on ClinicalTrials.gov

Determining the Viability a Lozenge Dosage for Probiotics

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

March 15, 2025

Study Completion Date

March 30, 2025

Conditions

Delivery SystemsOral Health

Interventions

DIETARY_SUPPLEMENT

Salivarius SALI-10

Lozenge with 10B CFU (Colony Forming Units)

Trial Locations (1)

M5G 1G6

Ostia Sciences Inc, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Ostia Sciences

INDUSTRY